Loading...
2494. Real-World Use of Ibalizumab in Physician Office Infusion Centers (POICs)
BACKGROUND: Ibalizumab-uiyk (IBA) was recently approved for the treatment of multi-drug-resistant HIV-1 infection in patients (pts) failing other antiretroviral regimens. Clinical trial data demonstrated a decrease in HIV-1 viral load in 83% and 43% of patients (n = 40) receiving IBA for 2 and 25 we...
Na minha lista:
| Udgivet i: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6809768/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.2172 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|